NBY Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.

$0.43  -0.02 (-3.41%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/26/2007
Outstanding shares:  44,943,364
Average volume:  968,175
Market cap:   $21,123,381
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    66987P201
ISIN:        US66987P2011
Valuation   (See tab for details)
PE ratio:   -2.67
PB ratio:   2.12
PS ratio:   2.75
Return on equity:   -60.24%
Net income %:   -96.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy